Profiling of circulating free DNA using targeted and genome wide sequencing in patients with Small Cell Lung Cancer

DOI: 10.1016/j.jtho.2019.10.007

Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance

DOI: 10.1016/j.ccell.2020.03.012

The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA

DOI: 10.1039/d0nh00333f

Expanding therapeutic opportunities for Extra-Pulmonary Neuroendocrine Carcinoma

DOI: 10.1158/1078-0432.CCR-21-3058

Circulating tumour DNA – looking beyond the blood

DOI: 10.1038/s41571-022-00660-y

Multi-maintenance olaparib therapy in relapsed, germline BRCA1/2-mutant high-grade serous ovarian cancer (MOLTO): a phase II trial 

DOI: 10.1158/1078-0432.CCR-22-3282

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

DOI: 10.1038/s41467-024-47195-7

Mining nucleic acid “omics” to boost liquid biopsy in cancer

DOI: 10.1016/j.xcrm.2024.101736

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial

DOI: 10.1136/bmjopen-2024-095560

MANIFEST: Multiomic Platform for Cancer Immunotherapy

DOI: 10.1158/2159-8290.CD-25-0099